Panelists discuss how the assessment and management of immune effector cell–associated neurotoxicity syndrome involves grading symptoms from mild to life-threatening, emphasizing the need for prompt recognition and rapid intervention to prevent progression and minimize long-term neurological damage.
Summary for Physicians:
Nonimmune Adverse Effects: Managing Dysgeusia and Fatigue
Challenges:
Both symptoms can be challenging to manage long term, requiring personalized strategies and regular assessment.
Stay up to date on recent advances in the multidisciplinary approach to cancer.